US FDA to spend $2.5 billion on IT modernisation
This article was originally published in Scrip
The US FDAwill award 10 contractors up to a total of $2.5 billion for information technology and data centre management services over the next 10 years. The agency says the contracts are the cornerstone of its IT modernisation programme encompassing data management, data warehousing, IT infrastructure and security. "This contract sets the stage for the FDA to have IT to acquire, analyse and act on data critical for import protection, food protection and medical product safety plans," FDA commissioner Dr Andrew von Eschenbach said. The FDA's IT infrastructure has been widely criticised as inadequate and outdated for the agency's functions, particularly its ability to oversee foreign drug manufacturers.
You may also be interested in...
With inspectors no longer out in the field, they have more time to wrap up work on previously completed facility evaluations, attorney Howard Sklamberg says; inspections freeze could delay manufacturers’ abilities to bring facilities into compliance following adverse inspection findings, as well as agency reclassifications of facility status.
Experience and data from the study, which will use the same vector platform to deliver different transgenes for different diseases, could feed into the US FDA’s efforts to establish a public-private partnership to enable manufacturing of gene therapies for ultra-rare diseases.
A protocol amendment is not needed to pause enrollment to decrease potential exposure to COVID-19, and virtual visits can be immediately implemented to ensure safety; experts say pandemic is forcing a rethinking in how companies carry out trials and in how regulators ensure patient safety and trial integrity.